GIO Therapeutics specialises in the development of G protein-coupled receptor (GPCR)-targeted pharmaceuticals. GIO’s innovative approach positions them to address complex challenges in oncology and inflammatory diseases. Its focus is not only to discover but to significantly improve patient outcomes.
GIO Therapeutics
